Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Alpha Cancer Technologies Inc.
DescriptionCombination of recombinant human alpha fetoprotein (AFP), a linker and maytansine
Molecular Target Alpha fetoprotein (AFP)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid and liquid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today